Summary
Quest Diagnostics Incorporated (DGX) filed an 8-K on February 21, 2008, to report its financial results for the fourth quarter and full year ended December 31, 2007. The report primarily serves to incorporate by reference a press release detailing these financial outcomes. While the 8-K itself does not contain the detailed financial figures, it directs investors to the attached press release (Exhibit 99.1) for comprehensive information regarding the company's performance. Investors interested in Quest Diagnostics' financial health, profitability, and operational performance for the period should consult this referenced press release for specific revenue, earnings, and other key financial metrics.
Key Highlights
- 1Quest Diagnostics filed an 8-K on February 21, 2008.
- 2The filing reports on the results for the quarter and twelve months ended December 31, 2007.
- 3The primary purpose of the 8-K is to announce the company's financial results and condition.
- 4Detailed financial information is provided in a press release attached as Exhibit 99.1.
- 5The press release is incorporated by reference into the 8-K filing.
- 6The Chief Financial Officer, Robert A. Hagemann, signed the report.
Frequently Asked Questions
The main purpose of this 8-K filing is to report Quest Diagnostics Incorporated's financial results for the fourth quarter and the full year ended December 31, 2007, and to formally include the associated press release containing these details.
The specific financial results are not detailed directly in the 8-K form itself. They are contained within the press release issued by Quest Diagnostics on February 21, 2008, which is attached as Exhibit 99.1 and incorporated by reference into this filing.
The report was signed by Robert A. Hagemann, Senior Vice President and Chief Financial Officer of Quest Diagnostics Incorporated.